R
Robert Kositchek
Researcher at St. Joseph Hospital
Publications - 9
Citations - 873
Robert Kositchek is an academic researcher from St. Joseph Hospital. The author has contributed to research in topics: Blood lipids & Infarction. The author has an hindex of 7, co-authored 9 publications receiving 870 citations.
Papers
More filters
Journal ArticleDOI
A Predictive Study of Coronary Heart Disease: The Western Collaborative Group Study
Ray H. Rosenman,Meyer Friedman,Reuben Straus,Moses Wurm,Robert Kositchek,Wilfrid Hahn,Nicholas T. Werthessen +6 more
TL;DR: The profile of coronary-prone males through retrospective analysis of prospectively obtained data is defined and higher serum beta/alpha lipoprotein ratios and 80 of them had been adjudged in "blind" assessments to exhibit an overt behavior pattern previously found associated with occurrence of CHD in middle-aged men are defined.
Journal ArticleDOI
The relationship of behavior pattern A to the state of the coronary vasculature. A study of fifty-one autopsy subjects.
TL;DR: It was found that subjects who while living succumbed to coronary artery disease six times more frequently than subjects who exhibited a converse pattern (type B) during their life.
Journal ArticleDOI
Clinically unrecognized myocardial infarction in the Western Collaborative Group Study.
TL;DR: Most cases of unrecognized infarction were associated with the Type A behavior pattern, and this was independent of the blood pressure, serum lipid or lipoprotein levels, cigarette smoking, parental history or any of the other factors under study.
Journal ArticleDOI
Recurring and fatal myocardial infarction in the Western Collaborative Group Study.
TL;DR: Trends characterizing the fatal compared with nonfatal cases included a higher frequency of cigarette smoking, elevated serum beta/alpha lipoprotein ratios and the Type A behavior pattern, which was observed both in subjects with fatal and those with nonFatal infarction.
Journal ArticleDOI
The Prediction of Immunity to Coronary Heart Disease
TL;DR: It was found that the normotensive, middle-aged man with the fully developed type B behavior pattern was essentially immune to the development of clinical CHD if he exhibited a serum cholesterol level less than 226 mg/100 ml, a serum triglyceride level more than 126 mg/ 100 ml, or a serum β-/α-lipoprotein ratio less than 2.01.